Drug Target Review

DECEMBER 20, 2024

Artificial intelligence (AI) has revolutionised many industries, yet its adoption in pharmaceutical drug development has been notably slower. For years, AI and machine learning (ML) were often dismissed as little more than advanced statistics with little practical value in drug development.

Clinical Trials 128

Clinical Trials Trials Pharmaceuticals Drug Development 128

BioPharma Drive: Drug Pricing

NOVEMBER 13, 2023

How can these increase the probability of success or efficiency in a pre-clinical and clinical drug development program? Regulatory agencies have set the framework and use cases for RWE.

Drug Development 274

Drug Development Pharmaceuticals Drugs 274

Drugs.com

MARCH 25, 2025

TUESDAY, March 25, 2025 -- Novo Nordisk, a Danish pharmaceutical company, has signed a major deal worth up to $2 billion for the rights to a new obesity and diabetes drug, the company announced March 24. The drug, called UBT251, is being developed.

Pharmaceutical Companies 263

Pharmaceutical Companies Drugs Pharmaceuticals 263

Drug Patent Watch

DECEMBER 10, 2024

India has long been recognized as a significant player in the global pharmaceutical industry, particularly in the production of generic drugs. The country’s pharmaceutical sector has experienced substantial growth over the years, driven by both domestic and international demand for affordable and high-quality medicines.

Government 93

Government Drugs Pharmacy Pharmaceuticals 93

Drugs.com

APRIL 4, 2024

THURSDAY, April 4, 2024 (HealthDayNews) -- Following disappointing trial results, the maker of a controversial ALS drug said it is pulling the medication off the market. In a statement issued Thursday, Amylyx Pharmaceuticals said that Relyvrio.

Marketing 279

Marketing Drugs Pharmaceuticals Trials 279

Drugs.com

MARCH 11, 2024

MONDAY, March 11, 2024 -- Following disappointing trial results, the maker of a controversial ALS drug may pull the medication off the market. In a statement issued Friday, Amylyx Pharmaceuticals said that Relyvrio failed to help patients in a.

Marketing 289

Marketing Trials Drugs Pharmaceuticals 289

BioPharma Drive: Drug Pricing

SEPTEMBER 20, 2023

Targeted protein degradation has emerged as one of the more competitive areas of pharmaceutical research in recent years as scientists develop new ways to reach difficult-to-drug targets.

Targeted Protein Degradation 274

Targeted Protein Degradation Drugs Pharmaceuticals Research 274

Drug Patent Watch

DECEMBER 9, 2024

In the vast realm of pharmaceutical research and development, there’s a fascinating intersection between ancient wisdom and modern science. This intersection is where pharmacognosy meets drug patents, creating a unique landscape that shapes the future of medicine. What is a Drug Patent?

Drugs 93

Drugs Drug Development Pharmaceuticals Production 93

Drug Patent Watch

MAY 14, 2025

"Reviving Old Medicines: How AI-Powered Repurposing is Revolutionizing the Pharmaceutical Industry The pharmaceutical industry is on the cusp of a revolution, driven by the power of computational drug repurposing. From treating cancer to Alzheimer's, the possibilities are endless. link] "

Drugs 84

Drugs Pharmaceuticals Disease Research 84

Drug Patent Watch

DECEMBER 10, 2024

The pharmaceutical industry has undergone significant changes over the past decade, with a growing trend towards outsourcing key aspects of research, development, and manufacturing to third-party vendors. The Rise of Integrated CDMOs The global biotechnology and pharmaceutical services outsourcing market size was valued at $70.48

Drug Development 87

Drug Development Compliance Pharmaceutical Companies Drugs 87

BioPharma Drive: Drug Pricing

JANUARY 31, 2025

After decades of research, Vertex Pharmaceuticals now has an approved pain medication. Can one of the world’s most powerful biotechs contend with a healthcare system that’s long favored opioids?

Pharmaceuticals 319

Pharmaceuticals Drugs Research 319

Drug Patent Watch

MAY 27, 2025

"Unlock Hidden Profits in Pharmaceutical R&D: A recent analysis of top-selling medications reveals that companies that closely monitor their competitors' patent portfolios are 3x more likely to achieve a higher return on investment in drug development. link] #pharmaceuticalinnovation #drugdevelopment #patentportfolio"

Drug Development 87

Drug Development Drugs Pharmaceuticals 87

Drug Patent Watch

DECEMBER 3, 2024

In the ever-evolving landscape of pharmaceutical research and development, a revolutionary force is reshaping the way we approach drug discovery and repurposing. This force is none other than Artificial Intelligence (AI) and Machine Learning (ML).

Drugs 91

Drugs Pharmaceuticals Research 91

BioPharma Drive: Drug Pricing

AUGUST 8, 2023

The Indianapolis drugmaker is now worth more than $500 billion, higher than any other pharmaceutical company, as analysts project lucrative markets for its obesity and Alzheimer's drugs.

Marketing 246

Marketing Pharmaceutical Companies Drugs Pharmaceuticals 246

Drug Patent Watch

MAY 5, 2025

"As the world grapples with the complexities of global healthcare, one nation is rewriting the rules of the pharmaceutical game: South Africa. From pioneering generic drug production to challenging Big Pharma's dominance, South Africa is redefining what it means to be a leader in the global pharmaceutical landscape.

Pharmaceuticals 85

Pharmaceuticals Production Drugs 85

Drug Patent Watch

DECEMBER 11, 2024

The pharmaceutical industry, particularly the generic drug sector, faces significant challenges in adopting sustainable practices. This article outlines key considerations and strategies for developing a sustainable generic drug development strategy. “Generics are known for their cost-effectiveness.

Drug Development 96

Drug Development Compliance Drugs Pharmaceuticals 96

Drug Patent Watch

NOVEMBER 11, 2024

Effective management of drug patent portfolios is crucial for pharmaceutical companies to maintain market exclusivity, protect revenue streams, and drive innovation. A robust patent strategy aligned with business goals is essential for maximizing value and staying competitive in the pharmaceutical landscape.

Pharmaceutical Companies 102

Pharmaceutical Companies Drugs Pharmaceuticals Marketing 102

BioPharma Drive: Drug Pricing

OCTOBER 13, 2023

Acquired with the buyout of Arena Pharmaceuticals, Velsipity enters a competitive market for ulcerative colitis pills.

FDA Approval 293

FDA Approval FDA Pharmaceuticals Marketing 293

Drug Patent Watch

DECEMBER 12, 2024

Identifying branded drugs with a low likelihood of generic entry has become a crucial strategy for companies looking to expand their product portfolio through in-licensing. This approach not only helps maintain market exclusivity but also ensures a steady revenue stream for pharmaceutical companies.

Licensing 87

Licensing Licensing Drugs Clinical Trials 87

Drug Patent Watch

DECEMBER 4, 2024

The pharmaceutical industry is undergoing a significant transformation with the advent of machine learning methods. These methods have the potential to revolutionize the drug discovery process by enhancing the efficiency and accuracy of identifying and developing new drug candidates.

Drug Development 93

Drug Development Drugs Pharmaceuticals 93

BioPharma Drive: Drug Pricing

APRIL 22, 2024

The acquisition of a Nexus Pharmaceuticals facility in Wisconsin could help Lilly better meet demand for injectable medicines, like those it makes for diabetes and obesity.

Pharmaceuticals 284

Pharmaceuticals Drugs 284

DrugBaron

FEBRUARY 16, 2024

“There is more than one way to skin a cat” is a rather gruesome British idiom, but its sentiment surely applies to running a successful pharmaceutical portfolio. But not everyone in drug development is playing this game. No wonder investing in drug development is so hard! But how do you know which game you are playing?

Drug Development 355

Drug Development Pharma Companies Drugs Science 355

Drug Patent Watch

OCTOBER 30, 2024

The pharmaceutical industry is known for its complex regulatory environment and lengthy product development processes. One often overlooked aspect of this industry is the potential benefits of abandoned and expired patents.

Pharmaceuticals 100

Pharmaceuticals Production Drugs Marketing 100

Drugs.com

MARCH 24, 2025

Food and Drug Administration (FDA) has approved a new drug for a serious heart condition that affects thousands of people. The drug, called Amvuttra (vutrisiran), is made by Alnylam Pharmaceuticals and is used to. MONDAY, March 24, 2025 -- The U.S.

FDA 279

FDA Pharmaceuticals Drugs 279

Drug Patent Watch

DECEMBER 8, 2024

The pharmaceutical industry is heavily reliant on patents to protect intellectual property and maintain market exclusivity. However, with the increasing competition from generic and biosimilar manufacturers, patent invalidity claims have become a significant challenge for pharmaceutical companies.

Biosimilars 96

Biosimilars Pharmaceutical Companies Drugs Pharmaceuticals 96

Drug Patent Watch

NOVEMBER 18, 2024

The concept of a blockbuster drug, defined as a medication generating at least $1 billion in annual sales, has long been a cornerstone of the pharmaceutical industry. However, the question arises whether a drug can achieve blockbuster status without heavily relying on U.S.

Drugs 96

Drugs Pharmaceuticals 96

Drug Patent Watch

DECEMBER 11, 2024

This growth has created a competitive landscape where pharmaceutical companies must carefully evaluate and select the right CDMO partner to ensure the success of their projects. Your Drugs Development Stage The stage of your drug development is a critical factor in selecting a CDMO.

Pharmaceutical Companies 96

Pharmaceutical Companies Compliance Pharmaceuticals Drug Development 96

BioPharma Drive: Drug Pricing

MARCH 12, 2024

Physicians are preparing for tough conversations with patients on Amylyx Pharmaceuticals’ drug, Relyvrio, while holding out hope it still may help some with the disease.

Doctors 313

Doctors Treatment Trials Pharmaceuticals 313

BioPharma Drive: Drug Pricing

AUGUST 21, 2024

Pharmaceuticals like the in-demand GLP-1 drugs for obesity are expected to drive increases in healthcare spending in 2025, per a new employer survey.

Pharmacy 284

Pharmacy Pharmaceuticals Drugs 284

PPD

NOVEMBER 11, 2024

It is hard to ignore some of the most pressing, long-term trends driving the push to accelerate innovation and progress in drug development. As a result, biopharma and biotech companies working to bring their drug pipelines to the market require deep expertise from trusted partners to help deliver critical therapies for their patients.

Drug Development 97

Drug Development Clinical Trials Drugs Small Molecule 97

Drug Patent Watch

MARCH 17, 2025

The Hidden Costs of Drug Patent Litigation: How to Stay Ahead of the Game As a pharmaceutical professional, you're no stranger to the complexities of drug patent litigation. In today's fast-paced pharmaceutical landscape, patent litigation is an inevitable reality. The stakes are high, and the costs can be astronomical.

Drugs 91

Drugs Pharmaceuticals 91

Drugs.com

JANUARY 30, 2024

For now, the drug from Vertex Pharmaceuticals is called VX-548. TUESDAY, Jan. 30, 2024 -- The first new kind of pain medication in over two decades could be on the horizon for patients, with promising results announced Tuesday from a company trial.

Pharmaceuticals 297

Pharmaceuticals Trials Drugs 297

Drug Patent Watch

DECEMBER 3, 2024

The process of obtaining a patent for a drug invention can be complex and time-consuming. Despite the best efforts of inventors and patent attorneys, many drug patent applications are rejected by patent offices. When facing a rejection… Source

Drugs 93

Drugs Pharmaceuticals 93

Drugs.com

JANUARY 31, 2025

Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin.The new pill, developed by Vertex Pharmaceuticals. FRIDAY, Jan. 31, 2025 -- The U.S.

FDA Approval 246

FDA Approval FDA Pharmaceuticals Drugs 246

Drug Patent Watch

OCTOBER 28, 2024

The pharmaceutical industry relies heavily on Contract Development and Manufacturing Organizations (CDMOs) to streamline the drug development and manufacturing process. CDMOs provide a wide range of services that cater to the diverse needs of pharmaceutical companies, from early-stage development to commercial manufacturing.

Pharmaceutical Companies 100

Pharmaceutical Companies Pharmaceuticals Drug Development Drugs 100

Drug Patent Watch

MAY 19, 2025

"Breaking the Chains of Exorbitant Medication Costs: How a New Approach to Biologic Drug Patents Could Save Lives and Billions As the cost of life-saving medications continues to skyrocket, a growing number of patients are being priced out of the healthcare system.

Drugs 79

Drugs Pharmaceuticals Treatment 79

Chemical Biology and Drug Design

JANUARY 5, 2025

5(4-Hydroxyphenyl)-2-(N-Phenyl amino)-1,3,4-Oxadiazole (Hppo) can considered as a versatile agent in designing novel pharmaceuticals. Thus, our findings can provide novel and versatile compounds for the development of multidirectional drugs in the pharmaceutical industry.

Bioinformatics 100

Bioinformatics Pharmaceuticals Drugs Research 100